GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmuCell Corp (NAS:ICCC) » Definitions » E10

ImmuCell (ImmuCell) E10 : $-0.15 (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is ImmuCell E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

ImmuCell's adjusted earnings per share data for the three months ended in Dec. 2023 was $-0.150. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.15 for the trailing ten years ended in Dec. 2023.

During the past 3 years, the average E10 Growth Rate was -55.40% per year. During the past 5 years, the average E10 Growth Rate was -23.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of ImmuCell was 171.40% per year. The lowest was -58.70% per year. And the median was 2.70% per year.

As of today (2024-05-16), ImmuCell's current stock price is $4.80. ImmuCell's E10 for the quarter that ended in Dec. 2023 was $-0.15. ImmuCell's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of ImmuCell was 378.00. The lowest was 81.60. And the median was 167.75.


ImmuCell E10 Historical Data

The historical data trend for ImmuCell's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmuCell E10 Chart

ImmuCell Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.05 -0.04 -0.03 -0.07 -0.15

ImmuCell Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.07 -0.11 -0.13 -0.14 -0.15

Competitive Comparison of ImmuCell's E10

For the Biotechnology subindustry, ImmuCell's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ImmuCell's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ImmuCell's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where ImmuCell's Shiller PE Ratio falls into.



ImmuCell E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, ImmuCell's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.15/129.4194*129.4194
=-0.150

Current CPI (Dec. 2023) = 129.4194.

ImmuCell Quarterly Data

per share eps CPI Adj_EPS
201403 -0.004 99.695 -0.005
201406 -0.100 100.560 -0.129
201409 0.003 100.428 0.004
201412 0.040 99.070 0.052
201503 0.150 99.621 0.195
201506 0.030 100.684 0.039
201509 0.110 100.392 0.142
201512 0.090 99.792 0.117
201603 0.110 100.470 0.142
201606 -0.002 101.688 -0.003
201609 0.010 101.861 0.013
201612 0.000 101.863 0.000
201703 0.120 102.862 0.151
201706 -0.050 103.349 -0.063
201709 -0.070 104.136 -0.087
201712 -0.040 104.011 -0.050
201803 -0.040 105.290 -0.049
201806 -0.150 106.317 -0.183
201809 -0.050 106.507 -0.061
201812 -0.190 105.998 -0.232
201903 0.030 107.251 0.036
201906 -0.090 108.070 -0.108
201909 -0.070 108.329 -0.084
201912 -0.060 108.420 -0.072
202003 -0.020 108.902 -0.024
202006 -0.110 108.767 -0.131
202009 -0.040 109.815 -0.047
202012 0.030 109.897 0.035
202103 -0.060 111.754 -0.069
202106 0.020 114.631 0.023
202109 0.020 115.734 0.022
202112 0.010 117.630 0.011
202203 0.070 121.301 0.075
202206 -0.090 125.017 -0.093
202209 -0.080 125.227 -0.083
202212 -0.210 125.222 -0.217
202303 -0.300 127.348 -0.305
202306 -0.180 128.729 -0.181
202309 -0.120 129.860 -0.120
202312 -0.150 129.419 -0.150

Add all the adjusted EPS together and divide 10 will get our e10.


ImmuCell  (NAS:ICCC) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of ImmuCell was 378.00. The lowest was 81.60. And the median was 167.75.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


ImmuCell E10 Related Terms

Thank you for viewing the detailed overview of ImmuCell's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


ImmuCell (ImmuCell) Business Description

Traded in Other Exchanges
Address
56 Evergreen Drive, Portland, ME, USA, 04103
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The firm has developed products that provide immediate immunity to newborn dairy and beef cattle and is developing product line extensions of its existing products that address mastitis. Its lead product, First Defense, is manufactured to prevent scours in newborn calves. It has two segments Scours and Mastitis. The company generates the majority of its revenue from the United States.
Executives
Bryan K. Gathagan director 56 EVERGREEN DRIVE, PORTLAND ME 04103
David Cunningham director 56 EVERGREEN DRIVE, PORTLAND ME 04103
Gloria F Basse director 56 EVERGREEN DRIVE, PORTLAND ME 04103
David Scott Tomsche director 56 EVERGREEN DRIVE, PORTLAND ME 04103
Steven T. Rosgen director C/O IMMUCELL CORPORATION, 56 EVERGREEN DR., PORTLAND ME 04103
Norman H Pessin other: See Explanation of Responses C/O LEVY, HARKINS & CO., INC., 366 MADISON AVENUE, 14TH FLOOR, NEW YORK NY 10017
Brian L. Pessin other: See Explanation of Responses 310 EAST 75TH STREET, APT. 2A, NEW YORK NY 10021
Joseph H Crabb director, officer: Vice President and CSO IMMUCELL CORP, 56 EVERGREEN DRIVE, PORTLAND ME 04103
Elizabeth Luttrell Williams officer: Vice Pres. of Mfg Operations C/O IMMUCELL CORPORATION, 56 EVERGREEN DRIVE, PORTLAND ME 04103
Jonathan E Rothschild director, 10 percent owner C/O IMMUCELL CORP, 56 EVERGREEN DRIVE, PORTLAND ME 04103
Linda Rhodes director 56 EVERGREEN DRIVE, PORTLAND ME 04103
Paul R Wainman director 56 EVERGREEN DRIVE, PORTLAND ME 04103
Michael F Brigham director, officer: President and CEO IMMUCELL CORP, 56 EVERGREEN DRIVE, PORTLAND ME 04103
Bobbi Jo Kunde other: Director of Sales and Marketin 56 EVERGREEN DRIVE, PORTLAND ME 04103
Robert C Bruce director 56 EVERGREEN DRIVE, PORTLAND ME 04103